Reference | Selection | Comparability | Outcome | Total criteria out of 9 | ||||||
1 | 2 | 3 | 4 | 1 | 2 | 1 | 2 | 3 | ||
Mark25 (USA, 2008) | ● | ● | ● | ● | ● | ● | ● | 7 | ||
Melville26 (USA, 2003) | ● | ● | ● | ● | ● | 5 | ||||
Meyer27 (USA, 2005) | ● | ● | ● | ● | ● | ● | ● | ● | 8 | |
Miyai28 (USA, 2004) | ● | ● | ● | ● | ● | ● | ● | 7 | ||
Narouz29 (UK, 2003) | ● | ● | ● | ● | ● | ● | 6 | |||
Richards30 (USA, 2007) | ● | ● | ● | ● | ● | ● | ● | ● | 8 | |
Rosenthal31 (USA, 2006) | ● | ● | ● | ● | ● | ● | ● | 7 | ||
Smith32 (AU, 2000) | ● | ● | ● | ● | ● | ● | 6 | |||
Wilkinson33 (UK, 2000) | ● | ● | ● | ● | ● | 5 |
Selection: 1, representativeness of the HSV-2-positive cohort; 2, selection of HSV-2-negative cohort; 3, ascertainment of serostatus; 4, demonstration that outcome of interest was not present at start of study.
Comparability: 1, study controls for previous HSV-2 diagnosis; 2, study controls for age or gender.
Outcome: 1, method for assessment of outcome; 2, sufficient follow-up; 3, sufficient participant retention in follow-up.
HSV, herpes simplex virus.